borderline significantp = 0.06
Importantly, nonresponders reported more negative symptom responses while taking pregabalin compared to placebo, although this difference was only borderline significant ( p = 0.06).
Importantly, nonresponders reported more negative symptom responses while taking pregabalin compared to placebo, although this difference was only borderline significant ( p = 0.06).